Delea, Thomas E.; Sofrygin, Oleg; Thomas, Simu K.; … - In: PharmacoEconomics 25 (2007) 4, pp. 329-342
Background: Deferasirox is a recently approved once-daily oral iron chelator that has been shown to reduce liver iron concentrations and serum ferritin levels to a similar extent as infusional deferoxamine. Objective: To determine the cost effectiveness of deferasirox versus deferoxamine in...